The Washington State College of Veterinary Medicine has just announced two clinical trials of therapy; one for dogs with nasal carcinomas and the other for arthritis of the elbow joint that hasn't responded to other therapies.
Nasal Cancer Study
For this study, researchers will be investigating the use of toceranib phosphate (Palladia™ ), a drug first approved to treat Mast Cell Tumors (MCT) in dogs.
Patient Criteria:
Dogs with a diagnosis of nasal carcinoma, that are greater than 24 months of age, greater than 6.8 pounds of body weight, have greater than a 6 week estimated life expectancy, and have adequate organ function. They may not have evidence of extension of tumor into the brain, lymph node or any other metastasis, another known serious disorder incompatible with the study, or be pregnant or lactating.
Learn more about this study:
- WSU Press Release on Nasal Carcinoma Study
- Contact Betsy Wheeler or Pam Thompson at the WSU VTH 509-335-0711
Elbow Osteoarthritis Study
This study will be looking at the use of low-dose radiation to control elbow pain from arthritis that is unresponsive to other treatments.
Patient Criteria
Dogs will be considered candidates for this study if they have a diagnosis of elbow arthritis in one or both elbows, and a noticeable gait abnormality due to the elbow arthritis, with minimal problems in other joints. They should be greater than 4 years of age but exceptions may be made.
Continued...
Learn more about this study:
- WSU Press Release on Osteoarthritis Study
- Contact Paula Bielenberg or Kelly Hughes (hughes@vetmed.wsu.edu) at the WSU VTH 335-0711.
Comments